Journal Mobile Options
Table of Contents
Vol. 70, No. 1, 2003
Issue release date: January 2003
Urol Int 2003;70:21–26

Augmentation Cystoplasty in Patients with Multiple Sclerosis

Zachoval R. · Pitha J. · Medova E. · Heracek J. · Lukes M. · Zalesky M. · Urban M.
Departments of aUrology and bNeurology, 3rd Faculty Hospital, Charles University, Prague, Czech Republic

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Introduction: Augmentation cystoplasty is an effective approach to the detrusor hyperreflexia which is refractory to conservative treatment. Sporadic data have been published in patients with progressive diseases such as multiple sclerosis (MS). Materials and Methods: Augmentation ileocystoplasty (Goodwin ‘cup-patch’) was performed in 9 patients (7 females, 2 males). The average Expanded Disability Status Scale score was 4.1 (range 3.0–6.5); 7 patients had relapse-remitting MS and 2 patients secondary-progressive MS. The indication was a detrusor hyperreflexia refractory to conservative treatment in 8 patients and a detrusor hyperrefluxia with third degree bilateral vesico-ureteral reflux and renal insufficiency in 1 patient. Pre- and postoperative objective parameters were evaluated by urodynamic examination, imaging methods and laboratory examination. Subjective evaluation was performed using a questionnaire on micturition symptoms (score 0–5) and on quality of life (score 0–6). Results: With a follow-up of 6–19 months, we recorded an average increase of the maximum detrusor capacity from 105 to 797 ml and decrease of maximum detrusor pressure from 53 to 30 cm H2O. Postmicturition residual urine >25% of the maximum capacity was present in 6 patients who performed clear intermittent autocatheterization postoperatively (2 patients preoperatively). In all patients there was a significant improvement in the irritation micturition symptomatology (pollakisuria, nycturia, urgency and urge incontinence) and the quality of life score improved on average from 5 to 0.7. In the case of the patient with renal insufficiency, the creatinine level decreased from 286 to 150 µmol/l; in the other patients renal function remained normal. Conclusions: Augmentation cystoplasty is a safe and effective method for indicated patients, which significantly enhances their quality of life.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Herschorn S, Hewitt RJ: Patient perspective of long-term outcome of augmentation cystoplasty for neurogenic bladder. Urology 1998;52:672–678.
  2. Mathoera RB, Kok DJ, Nijman MJ: Bladder calculi in augmentation cystoplasty in children. Urology 2000;56:482–487.
  3. Chartier-Kastler EJ, Mongiat-Artus P, Bitker MO, Chancellor MB, Richard F, Denys P: Long-term results of augmentation cystoplasty in spinal cord injury patients. Spinal Cord 2000;38:490–494.
  4. McInerney PD, DeSouza A, Thomas PJ, Mundy AR: The role of urodynamic studies in the evaluation of patients with augmentation cystoplasties. Br J Urol 1995;76:475–478.
  5. Fontaine E, Montgiat-Artus P, Desert JF, Barthelemy Y, Chartier E, Beurton D: Augmentation ileocystoplasty in neurologic bladder. Prog Urol 1996;6:901–906.
  6. Garcia DF, Fernandez FR, Guerreiro GR, del Valle GC: Substitution and augmentation enterocystoplasty: Long-term follow-up. Arch Esp Urol 1990;43:861–865.
  7. Haupt G, Pannek J, Knopf HJ, Schulze H, Senge T: Rupture of ileal neobladder due to urethral obstruction by mucous plug. J Urol 1990;144:740.
  8. Cetinel B, Demirkesen O, Onder AU, Yaycioglu O, Ismailoglu V, Solok V: Reconstructive surgery in voiding dysfunction: Experience with 69 patients. Urology 2000;56:962–966.
  9. Bauer SB, Hendren WH, Kozakewich H, et al: Perforation of the augmented bladder. J Urol 1992;148:699–703.
  10. Benchekroun A, Lachkar A, Hadab A, Soumana A, Farih MH, Belahnech Z, Marzouk M, Faik M: Augmentation cystoplasty: 35 cases. Ann Urol 1998;32:290–294.
  11. Dounis A, Gow JG: Bladder augmentation – A long-term review. Br J Urol 1979;51:264–268.
  12. Bondavalli C, Schiavon L, Dall’Oglio B, Luciano M, Bernardini P, Parma P, Parma A: Interstitial cystitis: Surgical treatment. Arch Ital Urol Androl 1999;71:327–332.
  13. Kvarstein B, Mathisen W: Sigmoidocystoplasty in adults with enuresis. Surg Gynecol Obstet 1981;153:65.
  14. Linder A, Leach GE, Raz S: Augmentation cystoplasty in the treatment of neurogenic bladder dysfunction. J Urol 1983;129:491–493.
  15. Sidi AA, Becher EF, Reddy PK, Dykstra DD: Augmentation enterocystoplasty for the management of voiding dysfunction in spinal cord injury patients. J Urol 1999;143:83–85.
  16. Awad SA, Al-Zahrani HM, Gajewski JB, Bourque-Kehoe AA: Long-term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women. Br J Urol 1998;81:569–573.
  17. Goldwasser B, Barrett DM, Webster D, Kramer SA: Cystometric properties of ileum and right colon after bladder augmentation, substitution or replacement. J Urol 1987;138:1007–1008.
  18. Sidi AA, Reinberg Y, Gonzales R: Influence of intestinal segment and configuration on the outcome of augmentation enterocystoplasty. J Urol 1986;136:1201.
  19. Smith RB, VanCangh P, Skinner DG, Kaufman JJ, Goodwin WE: Augmentation enterocystoplasty: A critical review. J Urol 1977;118:35–39.
  20. Cher ML, Allen TD: Continence in the myelodysplastic patients following enterocystoplasty. J Urol 1993;149:1103–1106.
  21. Lockhart JL, Bejany D, Politano VA: Augmentation cystoplasty in the management of neurogenic bladder disease and urinary incontinence. J Urol 1986;135:969–871.
  22. Shekarriz B, Upadhyay J, Demirbilek S, Barthold JS, Gonzalez R: Surgical complications of bladder augmentation: Comparison between various enterocystoplasties in 133 patients. Urology 2000;55:123–128.
  23. Venn SN, Mundy AR: Long-term results of augmentation cystoplasty. Eur Urol 1998;34:40–42.
  24. Holm J, Struckmann JR, Frimodt-Moller D: Augmentation ileo-cystoplasty in women with disabling urge incontinence. Ugeskr Læger 1995;157:1528.
  25. Mast P, Hoebeke P, Wyndaele JJ, Oosterlinck W, Everaert K: Experience with augmentation cystoplasty. A review. Paraplegia 1995;33:560–564.
  26. Decter RM, Bauer SB, Mandell J, Colodny AH, Retik AB: Small bowel augmentation in children with neurogenic bladder: An initial report of urodynamic findings. J Urol 1989;138:1014–1016.
  27. Murray KHA, Nurse DE, Mundy AR: Secretomotor function of intestinal segments used in lower urinary tract reconstruction. Br J Urol 1987;60:532–535.
  28. Khoury AE, Salomon M, Doche R, Soboh F, Ackerley C, Jayanthi R, McLorie GA, Mittelman MW: Stone formation after augmentation cystoplasty: The role of intestinal mucus. J Urol 1997;158:1133–1137.
  29. Bruce AW, Reid G, Chan RCV, Costeron JW: Bacterial adherence in the human ileal conduit: A morphological and bacteriological study. J Urol 1984;132:184.
  30. McDougal WS: Metabolic complications of urinary intestinal diversion. J Urol 1992;152:329–333.
  31. Couillard DR, Vapnek JM; Rentzepis MJ, Stone AR: Fatal perforation of augmentation cystoplasty in an adult. Urology 1993;42:585–588.
  32. Crane JM, Schertz HS, Bilman GF, et al: Ischemic necrosis: A hypothesis to explain the pathogenesis of spontaneous ruptured enterocystoplasty. J Urol 1991;146:141–144.
  33. Elder JS, Synder HM, Hulbert WC, et al: Perforation of the augmented bladder in patients undergoing clean intermittent catheterization. J Urol 1991;140:1159–1162.
  34. Scheiner JR, Kaplan GW: Spontaneous bladder rupture following enterocystoplasty. J Urol 1988;140:1157–1158.
  35. Blyth B, Ewalt DH, Duckett JW, Snyder HM: Lithogenic properties of enterocystoplasty. J Urol 1992;148:575.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50